| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 2,001,400 | 2,077,300 | 1,909,100 | 1,824,200 |
| Cost of products sold, excluding intangible asset amortization | 559,300 | 592,200 | 549,800 | 538,600 |
| Intangible asset amortization | 176,500 | 160,600 | 151,000 | 148,200 |
| Research and development | 115,900 | 113,300 | 110,600 | 111,600 |
| Selling, general and administrative | 811,400 | 814,800 | 758,800 | 709,700 |
| Restructuring and other cost reduction initiatives | 21,400 | 17,500 | 36,000 | 32,200 |
| Acquisition, integration, divestiture and related | -34,400 | 78,900 | 10,600 | 4,400 |
| Operating expenses | 1,650,100 | 1,777,300 | 1,616,800 | 1,544,700 |
| Operating profit | 351,300 | 300,000 | 292,300 | 279,500 |
| Other income, net | 3,300 | 3,900 | 2,900 | 5,100 |
| Interest expense, net | -75,400 | -79,300 | -66,200 | -54,300 |
| Earnings before income taxes | 279,200 | 224,600 | 229,000 | 230,300 |
| Provision (benefit) for income taxes | 48,000 | 71,200 | 46,500 | -18,900 |
| Net earnings | 231,200 | 153,400 | 182,600 | 249,200 |
| Less net earnings attributable to noncontrolling interest | 300 | 600 | 600 | 200 |
| Net earnings of zimmer biomet holdings, inc | 230,900 | 152,800 | 182,000 | 249,100 |
| Net earnings per common share - basic | 1.17 | 0.77 | 0.92 | 1.23 |
| Net earnings per common share - diluted | 1.16 | 0.77 | 0.91 | 1.23 |
| Weighted average number of shares outstanding, basic, total | 198,100,000 | 197,900,000 | 198,900,000 | 202,300,000 |
| Weighted average shares outstanding for diluted net earnings per share | 198,800,000 | 198,300,000 | 199,700,000 | 203,000,000 |
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
ZIMMER BIOMET HOLDINGS, INC. (ZBH)